About us

Our research program employs functionalized nanomaterials in medicine. We are a part of the Department of Biomedical Engineering. Our expertise is in the development of animal models of cancer, kidney disease and metals-related diseases, and in the development of engineered nanomaterials to diagnose, prevent and treat such diseases.

News

Aug 11, 2017
Yantasee Lab in collaboration with PDX Pharmaceuticals, LLC was recently awarded a $325,000 Phase I SBIR grant from the National Center for Advancing Translational Sciences, entitled Development of topical formulation of siRNA-nanoparticle for treating skin diseases, R43TR001906, from Aug 2017 to Aug 2018.

May 16, 2017
Yantasee Lab in collaboration with Dr. Joe Gray and PDX Pharmaceuticals, LLC was recently awarded a $1.7M Fast-Track Phase I/II SBIR grant from the National Cancer Institute, entitled Nanoparticle-based targeted co-delivery of siRNA and taxane to treat drug-resistant HER2+ breast cancer, R44CA217534, from May 2017 to May 2020.

About Dr. Yantasee

In addition to her position as Associate Professor at OHSU, Dr. Yantasee is also a Research Member of the Knight Cancer Institute and a Nanomedicine Signature Researcher at Oregon Nanoscience and Microtechnologies Institute (ONAMI).